AKBA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:03):
Our systems believe the stock currently is undervalued by 15.34% compare to its pairs and should correct upwards.

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases...

Stats
Dagens volum	4.68M
Gjennomsnittsvolum	4.34M
Markedsverdi	187.27M
EPS	$-0.0878 ( Q1 \| 2024-05-09 )
Neste inntjeningsdato	( $-0.0700 ) 2024-08-23
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.06 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00200 (0.22%)

AADI -8.24%

ABCL 1.28%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 3.73%

ABSI 3.91%

ABUS -0.82%

ABVX -3.00%

ACAD -0.32%

ACER -17.95%

ACET -9.15%

ACGN 1.29%

ACHL -2.48%

ACHV 3.66%

ACIU -1.50%

ACLX -0.44%

ACRV -5.28%

ACST -1.63%

ACXP 3.92%

ADAG 6.07%

ADAP -3.42%

ADGI 0.87%

ADIL -1.75%

ADMA -2.00%

ADPT 0.74%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -2.97%

AGEN -3.90%

AGIO -2.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.30%

AKRO -2.51%

AKTX 0.35%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC -0.11%

ALGS -1.52%

ALKS 1.61%

ALLK -11.44%

ALLO -4.17%

ALLR -2.11%

ALNA 3.16%

ALNY 2.20%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -14.31%

ALVR -0.76%

ALXN 0.00%

ALXO -14.18%

ALZN 4.02%

AMRN -2.48%

AMTI -3.13%

ANAB 1.01%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.96%

ANPC -3.15%

APGE 0.71%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.84%

APLT -1.13%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.47%

ARDS -12.13%

ARDX 0.41%

ARGX -0.59%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.85%

ARWR -1.86%

ASLN -3.44%

ASMB -4.22%

ASND -2.13%

ATAI -5.17%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 4.85%

ATRA -3.60%

ATXI -2.78%

ATXS -0.94%

AUPH -1.16%

AURA 4.11%

AUTL -3.17%

AVBP -5.03%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE -1.03%

AVTX -3.74%

AVXL -5.43%

AXLA 0.00%

AXSM -1.53%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -5.56%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.81%

BCTX 12.37%

BCTXW 13.02%

BCYC 1.00%

BDRX -4.01%

BDTX -0.64%

BEAM 2.19%

BFRA -2.91%

BGNE -2.25%

BIOR -4.69%

BIVI 2.79%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.18%

BLTE -1.13%

BLU 0.03%

BLUE -2.28%

BMEA -14.20%

BMRN 0.53%

BNOX 6.15%

BNTC -3.06%

BNTX -1.71%

BOLD -9.03%

BOLT -0.05%

BPMC -1.68%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -4.29%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.35%

CABA 1.66%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.43%

CARA -3.23%

CARM 6.93%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -1.68%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 8.28%

CELC -3.49%

CELU 1.33%

CELUW 11.80%

CERC -1.68%

CERE -1.61%

CERO -6.70%

CEROW -10.18%

CFRX -27.95%

CGEM -0.55%

CGEN -3.31%

CGON -1.45%

CGTX -3.98%

CHMA -6.00%

CHRS 3.79%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -1.13%

CLGN 0.00%

CLLS -3.11%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.04%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 4.00%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.67%

CNTB -0.75%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -2.28%

CORT 2.55%

COYA -0.33%

CPRX -1.91%

CRBP -0.83%

CRBU -7.10%

CRDF 0.66%

CRGX -0.34%

CRIS -1.59%

CRNX -6.19%

CRSP 0.02%

CRTX 2.63%

CRVO -3.95%

CRVS 0.28%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.40%

CUE -3.11%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.94%

CYTO 0.00%

DARE 2.94%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.32%

DNLI -2.17%

DNTH -6.46%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL 0.63%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.09%

EFTR 2.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.40%

ELEV -1.87%

ELOX 10.77%

ELTX -5.15%

ELVN -1.53%

ELYM 5.86%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.73%

ENTO -4.97%

ENTX -1.34%

ENVB 4.81%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.96%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.51%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.02%

EVLO 0.00%

EWTX -0.89%

EXAI -0.94%

EXEL 0.52%

EYEG -0.69%

EYEN 0.00%

EYPT 0.97%

FATE -11.96%

FBIO 0.59%

FBIOP 0.87%

FBLG -5.18%

FBRX -0.02%

FDMT -5.42%

FENC -2.52%

FGEN -9.83%

FHTX 7.34%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.57%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.49%

FULC 1.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -2.43%

GHRS -3.72%

GLMD -4.09%

GLPG -1.71%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -12.38%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.65%

GNPX -3.43%

GNTA 3.94%

GOSS -9.45%

GOVX -1.36%

GOVXW 10.89%

GPCR -7.01%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.44%

GRTX -1.66%

GTHX 1.82%

GUTS 0.35%

GXGXW 41.67%

GYRE -4.99%

HALO -1.65%

HARP 0.09%

HCWB -6.13%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.97%

HOTH -1.65%

HOWL 0.85%

HRMY 3.55%

HRTX 8.20%

HSTO 0.00%

HUMA 1.01%

HUMAW -6.26%

IBRX -6.74%

ICCC -3.10%

ICPT 0.21%

ICU 16.82%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.23%

IFRX -2.78%

IGMS -1.39%

IKNA -1.19%

IKT -9.93%

IMAB 0.00%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 3.64%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.38%

IMTXW 6.00%

IMUX 2.31%

IMV 0.00%

IMVT -3.52%

INAB -0.72%

INBX -2.65%

INCY -2.25%

INDP 7.34%

INFI -52.38%

INKT 1.69%

INM 3.32%

INMB 4.62%

INO 2.99%

INSM -1.03%

INTS -1.96%

INVA 0.40%

INZY 1.72%

IOBT -10.24%

IONS 1.21%

IOVA -2.72%

IPA 3.00%

IPHA 5.08%

IPSC -2.73%

IRON -2.67%

ISEE 0.38%

ITOS 1.98%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.05%

JANX -4.85%

JAZZ -1.10%

JNCE 0.00%

JSPR -2.49%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.16%

KDNY 0.22%

KMPH -0.34%

KNSA -2.03%

KNTE -0.38%

KOD -7.71%

KPRX -4.08%

KPTI -8.46%

KRBP -10.00%

KRON 1.58%

KROS -0.53%

KRRO -2.42%

KRTX 0.03%

KRYS 0.19%

KTRA 14.62%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.37%

KYTX -4.00%

KZIA 2.36%

KZR -1.48%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.77%

LENZ -2.77%

LEXX -1.54%

LEXXW -14.63%

LGND -1.18%

LGNDV 0.00%

LGVN -10.62%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA -0.16%

LRMR -0.07%

LSTA -1.68%

LTRN 5.74%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -2.06%

LYEL -35.05%

LYRA 2.99%

MACK 0.10%

MBIO -11.22%

MBRX -1.43%

MCRB 2.94%

MDGL -2.24%

MDNA -13.16%

MDWD 3.46%

MDXG -1.69%

MEIP 0.00%

MESO -1.71%

MGNX -5.36%

MGTA -7.74%

MGTX -0.71%

MGX 2.14%

MIRM 0.48%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX -0.03%

MLYS -6.49%

MNKD -0.76%

MNMD 2.97%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.20%

MREO 0.29%

MRKR -0.43%

MRNA -9.33%

MRNS -6.59%

MRSN -2.86%

MRTX -0.17%

MRUS -0.27%

MRVI -0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.00%

NAMSW -0.42%

NAUT 0.89%

NBRV 0.71%

NBSE -1.56%

NBTX 8.40%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.31%

NKGN 10.91%

NKGNW -18.03%

NKTR 3.74%

NKTX -3.50%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.94%

NMTR -42.97%

NOVN -24.84%

NRBO 14.44%

NRIX -0.79%

NRSN -2.74%

NRSNW 0.00%

NRXP -7.43%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.62%

NTEC -12.45%

NTHI 0.00%

NTLA -5.58%

NTRBW -31.07%

NUVL -1.41%

NVAX -6.93%

NVCT -7.46%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO 1.90%

OBSV 0.00%

OCEA -2.82%

OCGN 8.47%

OCS -1.00%

OCUL 0.76%

OCUP 1.31%

ODT -4.27%

OKYO 1.72%

OLMA -5.37%

OMER -2.57%

OMGA -0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -4.00%

ORGS -0.69%

ORIC -3.56%

ORMP 18.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX -0.14%

PDSB -6.66%

PEPG 1.37%

PGEN -7.19%

PHAR 2.19%

PHAS 0.00%

PHAT -0.87%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 7.39%

PMN -5.55%

PMVP -3.27%

PNT 0.16%

PPBT -6.87%

PRAX 6.98%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.67%

PRQR 1.21%

PRTA -2.99%

PRTC 0.62%

PRTG 0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.97%

PSTX -3.15%

PTCT -0.74%

PTE -0.82%

PTGX -1.06%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 3.76%

QLGN -2.78%

QNCX 5.70%

QNRX -0.08%

QSI -31.69%

QSIAW -20.47%

QTTB 1.83%

QURE -1.08%

RAIN -1.63%

RANI 4.81%

RAPT -2.27%

RARE 2.06%

RCKT -10.02%

REGN -0.39%

RENB -3.11%

REPL -2.38%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -6.07%

RGNX -6.66%

RIGL -6.24%

RLAY -4.97%

RLMD 0.00%

RLYB -4.36%

RNA 1.85%

RNAC -4.73%

RNAZ -0.66%

RNXT 1.79%

ROIV -1.94%

ROIVW 4.56%

RPHM -1.86%

RPRX -0.71%

RPTX -0.88%

RUBY 2.70%

RVLP -32.05%

RVMD -0.88%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.45%

RYTM -6.28%

RYZB 0.02%

RZLT 1.67%

SABS -1.37%

SABSW -11.81%

SAGE 0.05%

SANA -2.86%

SAVA -2.28%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 9.85%

SCPS 0.00%

SEEL -4.87%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.43%

SGMT -5.33%

SGTX -2.56%

SIOX 22.63%

SLDB -2.76%

SLGL 5.23%

SLN -7.52%

SLNO 0.62%

SLRX -0.81%

SLS -2.56%

SMMT -3.25%

SNDX 2.97%

SNGX 2.08%

SNPX 0.23%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.27%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -7.17%

STRO -2.51%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -1.97%

SWTX -0.47%

SYBX 1.29%

SYRS -2.24%

TALS -0.73%

TARA -7.38%

TARS -2.13%

TBPH 0.71%

TCBP 9.58%

TCDA 0.00%

TCON 0.68%

TCRR 0.00%

TCRT -1.75%

TCRX 3.39%

TECH -0.90%

TENX -0.32%

TERN -8.28%

TFFP -7.61%

TGTX -7.03%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.34%

TNXP -6.40%

TNYA -4.38%

TPST 5.78%

TRDA -4.77%

TRVI 2.68%

TRVN 0.68%

TSHA -19.03%

TSVT -4.25%

TTNP -6.05%

TVTX 3.20%

TYRA -6.83%

UBX -2.13%

UNCY -4.84%

URGN 2.30%

UTHR -0.11%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.91%

VBLT -8.77%

VCEL 0.98%

VCNX 8.60%

VCYT -1.01%

VERA -5.26%

VERU 2.58%

VERV -2.87%

VIGL -1.08%

VINC 2.93%

VIR -1.08%

VIRI -5.66%

VIRX 3.98%

VKTX -1.62%

VLON -13.04%

VNDA -4.07%

VOR -6.05%

VRCA 0.50%

VRDN -4.15%

VRNA -1.86%

VRPX 1.02%

VRTX 0.08%

VSTM 4.40%

VTGN -1.20%

VTVT 0.39%

VTYX -3.14%

VXRT -1.86%

VYGR -0.83%

VYNE -6.29%

VYNT 7.78%

WINT -2.72%

WVE -8.81%

XBIO 1.03%

XBIT 6.72%

XCUR 3.13%

XENE -1.77%

XERS 4.52%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -8.79%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.73%

ZNTL -2.02%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-06	Wolf Myles	Buy	30 000	Common Stock
2024-06-06	Wolf Myles	Buy	45 000	Stock Option (Right to buy)
2024-06-06	Smith Cynthia	Buy	30 000	Common Stock
2024-06-06	Smith Cynthia	Buy	45 000	Stock Option (Right to buy)
2024-06-06	Rogers Michael W	Buy	30 000	Common Stock

INSIDER POWER
86.90
Last 97 transactions
Buy: 10 736 838 \| Sell: 781 354

Korrelasjon (AI algo v.1.1b): Undervalued: 15.34% $1.031 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.34 (neutral)

Kort: -0.50 (weak negative)

Signal:(44.345) Neutral

Akebia Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
OZEM	1
ENTO	0.809

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Akebia Therapeutics Inc Korrelasjon - Valuta/Råvare

-0.70
( moderate negative )

-0.50
( weak negative )

0.00
( neutral )

-0.42
( neutral )

Akebia Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$194.62M
Bruttogevinst:	$118.89M (61.09 %)
EPS:	$-0.280

FY	2023
Omsetning:	$194.62M
Bruttogevinst:	$118.89M (61.09 %)
EPS:	$-0.280

FY	2022
Omsetning:	$292.60M
Bruttogevinst:	$207.81M (71.02 %)
EPS:	$-0.580

FY	2021
Omsetning:	$213.58M
Bruttogevinst:	$60.18M (28.18 %)
EPS:	$-1.700

Financial Reports:

No articles found.

Akebia Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Akebia Therapeutics Inc

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.